123
Participants
Start Date
December 31, 2021
Primary Completion Date
January 1, 2023
Study Completion Date
January 1, 2023
Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution
In the observational study, patients treated with topical antibiotic moxifloxacin 0.5% eye drops as part of routine medical care are observed. The investigator does not assign any specific intervention to the study participants.
Ceftazidime 5% + vancomycin 5%
In the observational study, patients treated with topical fortified antibiotics ceftazidime 5% and vancomycin 5% eye drops as part of routine medical care are observed. The investigator does not assign any specific intervention to the study participants.
Gentamicin 1.4% + vancomycin 5%
In the observational study, patients treated with the topical fortified antibiotics gentamicin 1.4% and vancomycin 5% eye drops as part of routine medical care are observed. The investigator does not assign any specific intervention to the study participants.
Natamycin 5% Oph Susp
In the observational study, patients treated with the topical natamycin 5% antifungal eye drops as part of routine medical care are observed. The investigator does not assign any specific intervention to the study participants.
Voriconazole 1%
In the observational study, patients treated with voriconazole 1% antifungal eye drops as part of routine medical care are observed. The investigator does not assign any specific intervention to the study participants.
Natamycin 5% + voriconazole 1%
In the observational study, patients treated with the topical natamycin 5% and voriconazole 1% antifungals eye drops as part of routine medical care are observed. The investigator does not assign any specific intervention to the study participants.
Natamycin 5%+ ceftazidime 5% + vancomycin 5%
In the observational study, patients treated with the topical natamycin 5% and antifungal and the fortified antibiotic ceftazidime 5% and vancomycin 5% eye drops as part of routine medical care are observed. The investigator does not assign any specific intervention to the study participants.
Voriconazole 1% + ceftazidime 5% + vancomycin 5%
In the observational study, patients treated with the topical voriconazole 1% antifungal and the fortified antibiotics ceftazidime 5% and vancomycin 5% eye drops as part of routine medical care are observed. The investigator does not assign any specific intervention to the study participants.
Cornea Outpatient Clinic at Alexandria Main University Hospital, Alexandria
Alexandria University
OTHER